Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400090637Phase 4Completed
Phase 4, randomised trial of remimazolam and propofol in bronchial carcinoma (3 arms), sponsored by Liaoning Province Cancer Hospital. Primary endpoint: Incidence of intraoperative hypotension. Started Oct 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400090637.